An Overview on Indole Aryl Sulfide/Sulfone (IAS) as Anti-HIV Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

被引：13
|
作者：
Sinha, Arun K. [1 ,2 ,3 ]
Equbal, Danish [1 ,4 ]
Rastogi, Sumit K. [1 ,2 ]
Kumar, Santosh [1 ,2 ]
Kumar, Ravindra [1 ,2 ]
机构：
[1] CSIR, Med & Proc Chem Div, Cent Drug Res Inst, Sect 10,Sitapur Rd, Lucknow 22603, Uttar Pradesh, India
[2] Acad Sci & Innovat Res AcSIR, Ghaziabad 201002, India
[3] Kolhan Univ Chaibasa, Chaibasa 833201, Jharkhand, India
[4] Sai Life Sci Ltd, Proc R&D, Hyderabad 500010, Telangana, India
来源：
ASIAN JOURNAL OF ORGANIC CHEMISTRY | 2022年 / 11卷 / 04期
关键词：
Arbidol; Indolearylsulfone; NNRTIs; Structure Activity Relationship (SAR); HUMAN-IMMUNODEFICIENCY-VIRUS; TUBULIN POLYMERIZATION; BIOLOGICAL EVALUATION; HIGHLY POTENT; WILD-TYPE; INDOLYLARYLSULFONES; DERIVATIVES; SULFONES; DESIGN; DISCOVERY;
D O I：
10.1002/ajoc.202100744
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
Sulfur-containing indoles are widely studied against different biological targets. Among several potential drug candidates, seven molecules of this class are in the current market and a few of them are either in pipeline or in different stages of clinical trials. Particularly, arylthioindoles or indolylarylsulfones (IAS) received great attention by medicinal chemists due to their pharmokinetic profiles and wide spectrum of biological activities like antiviral, anticancer, cardiovascular, and antibacterial properties. This review summarizes the developmental process, synthesis and structure activity relationship (SAR) around arylthioindole/indolylaryl sulfone scaffolds for antiviral/anti-HIV non-nucleoside reverse transcriptase inhibitor (NNRTIs) activities. It also offers perspective for further development of 3-indolylarylsulfones as an anti-viral agent including their potential against novel COVID-19 infection.
引用
收藏
页数：12
相关论文
共 50 条
  • [21] Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief overview of clinically approved drugs and combination regimens
    Vanangamudi, Murugesan
    Kurup, Sonali
    Namasivayam, Vigneshwaran
    CURRENT OPINION IN PHARMACOLOGY, 2020, 54 : 179 - 187
  • [22] Novel Cyclopropyl-Indole Derivatives as HIV Non-Nucleoside Reverse Transcriptase Inhibitors
    Hassam, Mohammad
    Basson, Adriaan E.
    Liotta, Dennis C.
    Morris, Lynn
    van Otterlo, Willem A. L.
    Pelly, Stephen C.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (06): : 470 - 475
  • [23] The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic
    Namasivayam, Vigneshwaran
    Vanangamudi, Murugesan
    Kramer, Victor G.
    Kurup, Sonali
    Zhan, Peng
    Liu, Xinyong
    Kongsted, Jacob
    Byrareddy, Siddappa N.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (10) : 4851 - 4883
  • [24] Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs) (vol , pg 554, 2008)
    Zhao, Zhijian
    Wolkenberg, Scott E.
    Sanderson, Philip E. J.
    Lu, Meiqing
    Munshi, Vandna
    Moyer, Gregory
    Feng, Meizhen
    Carella, Anthony V.
    Ecto, Linda T.
    Gabryelski, Lori J.
    Lai, Ming-Tain
    Prasad, Sridar G.
    Yan, Youwei
    McGaughey, Georgia B.
    Miller, Michael D.
    Lindsley, Craig W.
    Hartman, George D.
    Vacca, Joseph P.
    Williams, Theresa M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (17) : 5360 - 5360
  • [25] New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors
    Cushman, M
    Casimiro-Garcia, A
    Hejchman, E
    Ruell, JA
    Huang, MJ
    Schaeffer, CA
    Williamson, K
    Rice, WG
    Buckheit, RW
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (12) : 2076 - 2089
  • [26] Design, synthesis, anti-HIV activities, and metabolic stabilities of alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors
    Silvestri, MA
    Nagarajan, M
    De Clereq, E
    Pannecouque, C
    Cushman, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (12) : 3149 - 3162
  • [27] Development of non-nucleoside reverse transcriptase inhibitors(NNRTIs):our past twenty years
    Chunlin Zhuang
    Christophe Pannecouque
    Erik De Clercq
    Fener Chen
    ActaPharmaceuticaSinicaB, 2020, 10 (06) : 961 - 978
  • [28] Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase
    Sweeney, Zachary K.
    Acharya, Sahaja
    Briggs, Andrew
    Dunn, James P.
    Elworthy, Todd R.
    Fretland, Jennifer
    Giannetti, Anthony M.
    Heilek, Gabrielle
    Li, Yu
    Kaiser, Ann C.
    Martin, Michael
    Saito, Y. David
    Smith, Mark
    Suh, Judy M.
    Swallow, Steven
    Wu, Jeffrey
    Hang, Julie Q.
    Zhou, Amy S.
    Klumpp, Klaus
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (15) : 4348 - 4351
  • [29] Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years
    Zhuang, Chunlin
    Pannecouque, Christophe
    De Clercq, Erik
    Chen, Fener
    ACTA PHARMACEUTICA SINICA B, 2020, 10 (06) : 961 - 978
  • [30] Non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Proudfoot, JR
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (08) : 971 - 982
12345